Search Results - "Renbin Zhao"
-
1
The Demethylase Activity of FTO (Fat Mass and Obesity Associated Protein) Is Required for Preadipocyte Differentiation
Published in PloS one (28-07-2015)“…FTO (fat mass and obesity associated gene) was genetically identified to be associated with body mass index (BMI), presumably through functional regulation of…”
Get full text
Journal Article -
2
A Novel Inhibitor of the Obesity-Related Protein FTO
Published in Biochemistry (Easton) (15-03-2016)“…FeII and α-ketoglutarate-dependent fat mass and obesity associated protein (FTO)-dependent demethylation of m6A is important for regulation of mRNA splicing…”
Get full text
Journal Article -
3
Identification of A Novel Small-Molecule Binding Site of the Fat Mass and Obesity Associated Protein (FTO)
Published in Journal of medicinal chemistry (24-09-2015)“…N-(5-Chloro-2,4-dihydroxyphenyl)-1-phenylcyclobutanecarboxamide (N-CDPCB, 1a) is found to be an inhibitor of the fat mass and obesity associated protein (FTO)…”
Get full text
Journal Article -
4
Cytokines help suggest aplastic anemia with pulmonary bacterial or co-fungal infection
Published in Scientific reports (01-11-2022)“…Although aplastic anemia (AA) does not come under the category of blood malignant diseases, the infection that frequently occurs in this bone marrow failure…”
Get full text
Journal Article -
5
Cytokine Expression of Lung Bacterial Infection in Newly Diagnosed Adult Hematological Malignancies
Published in Frontiers in immunology (02-12-2021)“…Adult patients with hematological malignancies are frequently accompanied by bacterial infections in the lungs when they are first diagnosed. Sputum culture,…”
Get full text
Journal Article -
6
Increased Cytokine Levels Assist in the Diagnosis of Respiratory Bacterial Infections or Concurrent Bacteremia in Patients With Non-Hodgkin's Lymphoma
Published in Frontiers in cellular and infection microbiology (08-04-2022)“…Non-Hodgkin's lymphoma (NHL) is a form of tumor that originates in the lymphoid tissues. Bacterial infections are very common in NHL patients. Because most of…”
Get full text
Journal Article -
7
Traditional Chinese medicine compound, Bu Sheng Hui Yang Fang, promotes the proliferation of lymphocytes in the immunosuppressed mice potentially by upregulating IL-4 signaling
Published in Biomedicine & pharmacotherapy (01-02-2021)“…[Display omitted] •BSHY upregulates the numbers of lymphocytes in immunosuppressed mice.•BSHY increases proliferation and decreases apoptosis of…”
Get full text
Journal Article -
8
Analysis of p53-regulated gene expression patterns using oligonucleotide arrays
Published in Genes & development (15-04-2000)“…Oligonucleotide microarrays were employed to quantitate mRNA levels from a large number of genes regulated by the p53 transcription factor. Responses to DNA…”
Get full text
Journal Article -
9
SNPstream® UHT: Ultra-High Throughput SNP Genotyping for Pharmacogenomics and Drug Discovery
Published in BioTechniques (01-06-2002)“…Single nucleotide polymorphism (SNP) genotyping is playing an increasing role in genome mapping, pharmacogenetic studies, and drug discovery. To date,…”
Get full text
Journal Article -
10
Extracts from Glycine max (soybean) induce elastin synthesis and inhibit elastase activity
Published in Experimental dermatology (01-10-2009)“…: Elastic fibres are essential extracellular matrix components of the skin, contributing to its resilience and elasticity. In the course of skin ageing,…”
Get full text
Journal Article -
11
Characterization of GDF-10 Expression Patterns and Null Mice
Published in Developmental biology (01-08-1999)“…Growth/differentiation factor-10 (GDF-10) is a TGF-β family member highly related to bone morphogenetic protein-3. In order to determine the biological…”
Get full text
Journal Article -
12
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study Evaluating the Efficacy and Safety of Orelabrutinib Plus R-CHOP Versus Placebo Plus R-CHOP in Treatment-Naïve Patients with Mcd Subtype Diffuse Large B-Cell Lymphoma
Published in Blood (15-11-2022)Get full text
Journal Article -
13
Phase I result of ICP-192 (gunagratinib), a highly selective irreversible FGFR inhibitor, in patients with advanced solid tumors harboring FGFR pathway alterations
Published in Journal of clinical oncology (20-05-2021)“…Abstract only 4092 Background: ICP-192 (gunagratinib), developed by InnoCare Pharma, is a novel pan-FGFR (fibroblast growth factor receptors) inhibitor that…”
Get full text
Journal Article -
14
Changes in expression levels of immune cells and inflammatory cytokines in pre-eclampsia patients before and after delivery
Published in Journal of reproductive immunology (01-03-2023)“…By analyze the expression levels of immune cells and cytokines secreted by preeclampsia patients before and after delivery. Furthermore, to determine the…”
Get full text
Journal Article -
15
Phase I results of gunagratinib (ICP-192), a highly selective irreversible FGFR 1-4 inhibitor in patients with head and neck cancer harboring FGF/FGFR gene aberrations
Published in Journal of clinical oncology (01-06-2022)“…6039 Background: The fibroblast growth factor (FGF) and FGF receptor (FGFR) signaling pathway has been evaluated as critical driver of carcinogenesis in…”
Get full text
Journal Article -
16
Safety, pharmacokinetics (PK), and clinical efficacy of ICP-723, a highly selective next-generation pan-TRK inhibitor, in patients with solid tumor
Published in Journal of clinical oncology (01-06-2022)“…3106 Background: NTRK gene fusion resulting from NTRK1/2/3 genetic alterations occurs in various adult and pediatric cancers, which is one of the most defined…”
Get full text
Journal Article -
17
Orelabrutinib Monotherapy in Patients with Relapsed or Refractory Waldenström's Macroglobulinemia in a Single-Arm, Multicenter, Open-Label, Phase 2 Study: Long Term Follow-up Results
Published in Blood (02-11-2023)“…Background Orelabrutinib is a novel, small molecule, selective irreversible Bruton tyrosine kinase inhibitor, approved in China for the treatment of patients…”
Get full text
Journal Article -
18
Abstract CT132: Orelabrutinib, a potent and selective Bruton's tyrosine kinase inhibitor with superior safety profile and excellent PK/PD properties
Published in Cancer research (Chicago, Ill.) (15-08-2020)“…Abstract Bruton's tyrosine kinase (BTK) as a therapeutic target for B-cell malignancies, including mantle cell lymphoma (MCL), chronic lymphocytic…”
Get full text
Journal Article -
19
Clinical Observation on 98 Cases of Hematological Malignancies Treated with Autologous Hematopoietic Stem Cell Transplantation Cryopreserved By Ladder-Style Freezing from Low Temperature Refrigerator to Liquid Nitrogen
Published in Blood (08-12-2017)“…Background: Programmed cooling - 196℃ liquid nitrogen preservation and non- programmed cooling - 80℃ low temperature refrigerator preservation have been widely…”
Get full text
Journal Article -
20
Analysis of cytokine risk factors in the early death of patients with secondary phagocytic lymphocytic histiocytosis
Published in American journal of translational research (01-01-2021)“…Secondary hemophagocytic lymphohistiocytosis (sHLH) is an excessive inflammatory response syndrome caused by immune abnormalities. Up to date, the risk factors…”
Get full text
Journal Article